Skip to main content
RXRX logo
RXRX
(NASDAQ)
Recursion Pharmaceuticals, Inc.
$3.11-- (--)
Loading... - Market loading

Recursion Pharmaceuticals (RXRX) Income Statement

Revenue, expenses, profit margins, and earnings with annual and quarterly data.

Recursion Pharmaceuticals Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
Recursion Pharmaceuticals, Inc. income statement - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Revenue & Gross Profit
Revenue74.6858.8443.8839.6810.183.411.71
Cost of Revenue70.9545.2442.5948.28135.270.0045.81
Gross Profit-46.27-300.821.29-8.59-125.093.41-44.10
Operating Expenses
Research & Development475.27314.42241.23155.70135.2763.3245.81
Selling, General & Administrative176.59178.18110.8281.6057.6825.2618.95
Operating Expenses601.86178.18351.35237.1357.6888.0364.15
Operating Income-648.13-479.00-350.06-245.73-182.78-84.62-62.44
Other Income/Expense
Interest Income22.7915.7619.126.250.070.341.74
Interest Expense1.81-1.570.100.06-2.951.360.64
Other Income/Expense3.240.0317.930.050.00-2.390.56
Income
Income Before Tax-644.90-464.79-332.13-239.48-186.48-87.01-61.88
Income Tax Expense-0.14-1.13-4.060.000.000.000.00
Net Income-644.76-463.66-328.07-239.48-186.48-87.01-62.53
Net Income - Continuous Operations-644.76-463.66-328.07-239.48-186.48-87.01-62.53
Net Income - Discontinued Operations0.000.000.000.000.000.000.00
EBITDA-564.43-442.51-307.63-227.67-174.37-81.70-58.34
EBIT-648.13-479.00-332.03-239.42-182.78-84.620.00
Depreciation & Amortization83.7036.4924.4011.768.413.943.54
Earnings Per Share
Basic EPS-1.00-2.00-2.00-1.00-1.00-1.00-
Diluted EPS-1.00-2.00-2.00-1.00-1.00-1.00-
Basic Shares Outstanding447.45274.21207.85175.54125.35165.79165.79
Diluted Shares Outstanding447.45274.21207.85175.54125.35165.79165.79

Frequently Asked Questions About Recursion Pharmaceuticals Financial Statements

What is an income statement?

An income statement shows a company's revenues, expenses, and net income over a specific period. It reveals profitability by starting with revenue and subtracting costs to arrive at net income — the "bottom line" that shows how much the company earned.

What is RXRX's revenue trend?

Review Recursion Pharmaceuticals's quarterly and annual revenue figures in the income statement table above to identify growth trends, seasonal patterns, and year-over-year changes.

What is gross margin?

Gross margin is revenue minus cost of goods sold, expressed as a percentage. It shows how efficiently a company produces its goods or services. Higher gross margins indicate stronger pricing power and lower production costs.

What is operating income?

Operating income (EBIT) is revenue minus operating expenses, excluding interest and taxes. It measures a company's core business profitability before financing costs and tax effects, making it useful for comparing companies with different capital structures.

What is earnings per share (EPS)?

EPS divides net income by outstanding shares, showing the profit attributable to each share. Diluted EPS includes potential shares from stock options and convertible securities, providing a more conservative measure of per-share earnings.